BioNTech and InstaDeep announce a strategic collaboration. The transaction will combine InstaDeep's advanced artificial intelligence, machine learning and digitalization capabilities with BioNTech's in-depth expertise in precision immunotherapy and access to a wide range of internal and external data sets. One of the key research areas will be the development of next-generation vaccines and biopharmaceuticals to treat cancer and prevent and treat infectious diseases, including Covid-19.